Can Low-Dose Immunotherapy Expand Global Access to Cancer Care?

ASCO Daily News by American Society of Clinical Oncology (ASCO)

Feb 5, 202614:53Science & Medicine

Dr. Monty Pal and Dr. Atul Batra discuss the PLANeT study from India, which evaluated low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer, and its place among a growing body o...

Related Episodes

Continue listening to more episodes from ASCO Daily News.

Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1

Jun 30, 2026 - 24:37

Dr. Megan Kruse and Dr. Hope Rugo discuss practice-changing data in metastatic breast cancer and critical...

GU Cancer Highlights From ASCO26: PROTEUS, TALAPRO-3, and RAMPART

Jun 25, 2026 - 30:28

Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss high-impact abstracts in the treatment of prostate...

Immunotherapy Highlights From ASCO26: Cellular Therapy, Melanoma, and Skin Cancers

Jun 24, 2026 - 29:43

Dr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in m...

GI Cancer Highlights From ASCO26: RASolute-302, BREAKWATER, and More

Jun 23, 2026 - 22:46

Dr. Nilo Azad and Dr. Aparna Parikh discuss high-impact studies in gastrointestinal cancers and other nov...

Hematologic Cancer Highlights From ASCO26: MajesTEC-9, frontMIND, and More

Jun 19, 2026 - 25:05

Dr. Marc Braunstein and Dr. Adam Kittai highlight top research on hematologic malignancies from the 2026...

Lung Cancer Highlights From ASCO26: HARMONi-6, LIBRETTO-436, and More

Jun 18, 2026 - 22:54

Dr. Christine Lovly and Dr. Vamsi Velcheti discuss practice-changing lung cancer data presented at the 20...

Day 5: Top Takeaways From ASCO26

Jun 2, 2026 - 09:35

Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia i...

Day 4: Top Takeaways From ASCO26

Jun 1, 2026 - 08:45

Dr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated...